StonvexLoading…
StonvexStonvexStonvexCore line items from CHE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 |
|---|---|---|---|---|
Revenue | $1.53B | $1.12B | $728.56M | $354.01M |
Operating Income | $366.49M | $252.62M | $160.46M | $72.33M |
Net Income | $302.00M | $211.68M | $135.90M | $65.02M |
EPS (Diluted) | $19.89 | $13.88 | $8.89 | $4.24 |
Total Assets | $1.67B | $1.77B | $1.73B | $1.73B |
Total Liabilities | $549.58M | $533.68M | $527.69M | $544.14M |
Cash & Equivalents | $178.35M | $238.45M | $222.90M | $313.35M |
Free Cash Flow OCF − CapEx | $367.97M | $215.81M | $138.84M | $72.39M |
Shares Outstanding | 15.19M | 15.25M | 15.29M | 15.34M |